1. Home
  2. FOLD
  3. FOLD News

Latest Amicus Therapeutics Inc. (FOLD) News on December 22, 2024

Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?
FOLD

Benzinga

9 days ago

Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?

Amicus Therapeutics (FOLD) is a Top-Ranked Momentum Stock: Should You Buy?
FOLD

Zacks

9 days ago

Amicus Therapeutics (FOLD) is a Top-Ranked Momentum Stock: Should You Buy?

FOLD

MT Newswires

9 days ago

Morgan Stanley Downgrades Amicus Therapeutics to Equalweight From Overweight, Cuts Price Target to $12 From $17

Why Is Amicus Therapeutics (FOLD) Down 11.1% Since Last Earnings Report?
FOLD

Zacks

16 days ago

Why Is Amicus Therapeutics (FOLD) Down 11.1% Since Last Earnings Report?

HALO vs. FOLD: Which Stock Is the Better Value Option?
FOLD

Zacks

17 days ago

HALO vs. FOLD: Which Stock Is the Better Value Option?

Exploring High Growth Tech Stocks In The United States December 2024
FOLD

Simply Wall St.

19 days ago

Exploring High Growth Tech Stocks In The United States December 2024

HALO vs. FOLD: Which Stock Should Value Investors Buy Now?
FOLD

Zacks

a month ago

HALO vs. FOLD: Which Stock Should Value Investors Buy Now?

Amicus Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
FOLD

Simply Wall St.

a month ago

Amicus Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Amicus' Q3 Earnings & Revenues Beat Estimates, '24 View Updated
FOLD

Zacks

a month ago

Amicus' Q3 Earnings & Revenues Beat Estimates, '24 View Updated

Here's Why Amicus Therapeutics (FOLD) is a Strong Momentum Stock
FOLD

Zacks

a month ago

Here's Why Amicus Therapeutics (FOLD) is a Strong Momentum Stock

Amicus Therapeutics Inc (FOLD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
FOLD

GuruFocus.com

a month ago

Amicus Therapeutics Inc (FOLD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

FOLD

Thomson Reuters StreetEvents

a month ago

Q3 2024 Amicus Therapeutics Inc Earnings Call

Here's What Key Metrics Tell Us About Amicus Therapeutics (FOLD) Q3 Earnings
FOLD

Zacks

2 months ago

Here's What Key Metrics Tell Us About Amicus Therapeutics (FOLD) Q3 Earnings

Amicus Therapeutics (FOLD) Q3 Earnings and Revenues Beat Estimates
FOLD

Zacks

2 months ago

Amicus Therapeutics (FOLD) Q3 Earnings and Revenues Beat Estimates

FOLD

MT Newswires

2 months ago

Amicus Therapeutics Swings to Q3 Non-GAAP Net Income, Sales Gain; Raises 2024 Revenue Growth Guidance; Shares Rise Pre-Bell

FOLD

Associated Press Finance

2 months ago

Amicus Therapeutics: Q3 Earnings Snapshot

Amicus Therapeutics Announces Third Quarter 2024 Financial Results and Corporate Updates
FOLD

GlobeNewswire

2 months ago

Amicus Therapeutics Announces Third Quarter 2024 Financial Results and Corporate Updates

Wall Street Analysts Predict a 51.09% Upside in Amicus Therapeutics (FOLD): Here's What You Should Know
FOLD

Zacks

2 months ago

Wall Street Analysts Predict a 51.09% Upside in Amicus Therapeutics (FOLD): Here's What You Should Know

Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024
FOLD

GlobeNewswire

2 months ago

Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024

Will Mirum Pharmaceuticals, Inc. (MIRM) Report Negative Q3 Earnings? What You Should Know
FOLD

Zacks

2 months ago

Will Mirum Pharmaceuticals, Inc. (MIRM) Report Negative Q3 Earnings? What You Should Know

Amicus Therapeutics (FOLD) Reports Next Week: Wall Street Expects Earnings Growth
FOLD

Zacks

2 months ago

Amicus Therapeutics (FOLD) Reports Next Week: Wall Street Expects Earnings Growth

Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024
FOLD

GlobeNewswire

2 months ago

Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024

GitLab and Baidu have been highlighted as Zacks Bull and Bear of the Day
FOLD

Zacks

2 months ago

GitLab and Baidu have been highlighted as Zacks Bull and Bear of the Day

Best Momentum Stocks to Buy for October 24th
FOLD

Zacks

2 months ago

Best Momentum Stocks to Buy for October 24th

Why Amicus Therapeutics (FOLD) is a Top Momentum Stock for the Long-Term
FOLD

Zacks

2 months ago

Why Amicus Therapeutics (FOLD) is a Top Momentum Stock for the Long-Term

Can Amicus Therapeutics (FOLD) Run Higher on Rising Earnings Estimates?
FOLD

Zacks

2 months ago

Can Amicus Therapeutics (FOLD) Run Higher on Rising Earnings Estimates?

FOLD Stock Rises on Settling Galafold Patent Dispute With Teva
FOLD

Zacks

2 months ago

FOLD Stock Rises on Settling Galafold Patent Dispute With Teva

How Much Upside is Left in Amicus Therapeutics (FOLD)? Wall Street Analysts Think 43.44%
FOLD

Zacks

2 months ago

How Much Upside is Left in Amicus Therapeutics (FOLD)? Wall Street Analysts Think 43.44%

Amicus Therapeutics (FOLD) Just Flashed Golden Cross Signal: Do You Buy?
FOLD

Zacks

2 months ago

Amicus Therapeutics (FOLD) Just Flashed Golden Cross Signal: Do You Buy?

Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar?
FOLD

Zacks

2 months ago

Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar?

FOLD

MT Newswires

2 months ago

Update: Amicus Therapeutics Shares Surge After Settling Patent Suit Against Teva Pharmaceuticals With License Deal

Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug
FOLD

Benzinga

2 months ago

Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug

FOLD

MT Newswires

2 months ago

Amicus Therapeutics Settles Patent Suit Against Teva Pharmaceuticals with License Agreement

Amicus Therapeutics Announces Settlement of Galafold® (migalastat) Patent Litigation with Teva
FOLD

GlobeNewswire

2 months ago

Amicus Therapeutics Announces Settlement of Galafold® (migalastat) Patent Litigation with Teva

Exploring Three High Growth Tech Stocks in the United States
FOLD

Simply Wall St.

2 months ago

Exploring Three High Growth Tech Stocks in the United States

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Is Expected To Breakeven In The Near Future
FOLD

Simply Wall St.

2 months ago

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Is Expected To Breakeven In The Near Future

Amicus Therapeutics Inc (FOLD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...
FOLD

GuruFocus.com

2 months ago

Amicus Therapeutics Inc (FOLD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...

JPMorgan Chase & Co's Strategic Reduction in Amicus Therapeutics Inc
FOLD

GuruFocus.com

2 months ago

JPMorgan Chase & Co's Strategic Reduction in Amicus Therapeutics Inc

Amicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024
FOLD

GlobeNewswire

3 months ago

Amicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024

Is Amicus Therapeutics, Inc. (FOLD) the Best Guru Stock To Buy Now?
FOLD

Insider Monkey

3 months ago

Is Amicus Therapeutics, Inc. (FOLD) the Best Guru Stock To Buy Now?

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
FOLD

Zacks

4 months ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

FOLD

MT Newswires

4 months ago

Jefferies Initiates Amicus Therapeutics at Buy

High Growth Tech Stocks To Watch In The United States
FOLD

Simply Wall St.

4 months ago

High Growth Tech Stocks To Watch In The United States

UPDATE -- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
FOLD

GlobeNewswire

4 months ago

UPDATE -- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024

Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
FOLD

GlobeNewswire

4 months ago

Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024

Amicus Therapeutics Announces Participation at the SSIEM 2024 Annual Symposium
FOLD

GlobeNewswire

4 months ago

Amicus Therapeutics Announces Participation at the SSIEM 2024 Annual Symposium

Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
FOLD

GlobeNewswire

4 months ago

Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024

Amicus (FOLD) Banks on Galafold, High Dependence a Concern
FOLD

Zacks

4 months ago

Amicus (FOLD) Banks on Galafold, High Dependence a Concern

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
FOLD

Zacks

4 months ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Amicus (FOLD) Up as Q2 Earnings & Sales Top, '24 View Updated
FOLD

Zacks

4 months ago

Amicus (FOLD) Up as Q2 Earnings & Sales Top, '24 View Updated

Amicus Therapeutics (FOLD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
FOLD

Zacks

4 months ago

Amicus Therapeutics (FOLD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

FOLD

MT Newswires

4 months ago

Amicus Therapeutics Swings to Q2 Non-GAAP Net Income as Sales Rise; 2024 Revenue Growth Guidance Lifted

Amicus Therapeutics (FOLD) Q2 Earnings and Revenues Top Estimates
FOLD

Zacks

4 months ago

Amicus Therapeutics (FOLD) Q2 Earnings and Revenues Top Estimates

FOLD

Associated Press Finance

4 months ago

Amicus Therapeutics: Q2 Earnings Snapshot

Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate Updates
FOLD

GlobeNewswire

4 months ago

Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate Updates

Amicus Therapeutics to Announce Second Quarter 2024 Financial Results on August 8, 2024
FOLD

GlobeNewswire

5 months ago

Amicus Therapeutics to Announce Second Quarter 2024 Financial Results on August 8, 2024

Do Options Traders Know Something About Amicus (FOLD) Stock We Don't?
FOLD

Zacks

6 months ago

Do Options Traders Know Something About Amicus (FOLD) Stock We Don't?

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
FOLD

Simply Wall St.

6 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North
FOLD

AFP

6 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
FOLD

Simply Wall St.

6 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m
FOLD

Simply Wall St.

6 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week
FOLD

Barrons.com

6 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend
FOLD

Simply Wall St.

6 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued
FOLD

Simply Wall St.

6 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Should You Buy OVB Holding AG (ETR:O4B) For Its Upcoming Dividend?
FOLD

Simply Wall St.

6 months ago

Should You Buy OVB Holding AG (ETR:O4B) For Its Upcoming Dividend?

Investors in Amicus Therapeutics (NASDAQ:FOLD) from a year ago are still down 19%, even after 3.9% gain this past week
FOLD

Simply Wall St.

6 months ago

Investors in Amicus Therapeutics (NASDAQ:FOLD) from a year ago are still down 19%, even after 3.9% gain this past week

Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
FOLD

GlobeNewswire

7 months ago

Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) as Best Pharmaceutical Product
FOLD

GlobeNewswire

7 months ago

Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) as Best Pharmaceutical Product

FOLD

MT Newswires

7 months ago

Wells Fargo Starts Amicus Therapeutics With Overweight Rating, $18 Price Target

Do Options Traders Know Something About Amicus (FOLD) Stock We Don't?
FOLD

Zacks

7 months ago

Do Options Traders Know Something About Amicus (FOLD) Stock We Don't?

FOLD

MT Newswires

7 months ago

Guggenheim Upgrades Amicus Therapeutics to Buy From Neutral With $13 Price Target

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript
FOLD

Insider Monkey

7 months ago

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript

FOLD

GuruFocus.com

7 months ago

Amicus Therapeutics Inc (FOLD) Q1 2024 Earnings: Surpasses Revenue Estimates and Projects ...

FOLD

MT Newswires

7 months ago

UBS Trims Price Target on Amicus Therapeutics to $19 From $20, Keeps Buy Rating

Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
FOLD

Zacks

7 months ago

Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated

Amicus Therapeutics (FOLD) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
FOLD

Zacks

7 months ago

Amicus Therapeutics (FOLD) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

FOLD

MT Newswires

7 months ago

Amicus Therapeutics' Q1 Net Loss Narrows, Net Product Sales Rise

Amicus Therapeutics (FOLD) Reports Q1 Loss, Lags Revenue Estimates
FOLD

Zacks

7 months ago

Amicus Therapeutics (FOLD) Reports Q1 Loss, Lags Revenue Estimates

FOLD

Associated Press Finance

7 months ago

Amicus Therapeutics: Q1 Earnings Snapshot

Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates
FOLD

GlobeNewswire

7 months ago

Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates

Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference
FOLD

GlobeNewswire

7 months ago

Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference

ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
FOLD

Zacks

8 months ago

ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know
FOLD

Zacks

8 months ago

Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know

Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024
FOLD

GlobeNewswire

8 months ago

Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024

When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable?
FOLD

Simply Wall St.

8 months ago

When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable?

Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report?
FOLD

Zacks

9 months ago

Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report?

Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report
FOLD

GlobeNewswire

9 months ago

Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report

13 Best Biotech Stocks To Buy Under $20
FOLD

Insider Monkey

9 months ago

13 Best Biotech Stocks To Buy Under $20

Director Margaret Mcglynn Sells 15,000 Shares of Amicus Therapeutics Inc (FOLD)
FOLD

GuruFocus.com

10 months ago

Director Margaret Mcglynn Sells 15,000 Shares of Amicus Therapeutics Inc (FOLD)

Amicus Therapeutics Stock Sees RS Rating Improve To 74
FOLD

Investor's Business Daily

10 months ago

Amicus Therapeutics Stock Sees RS Rating Improve To 74

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
FOLD

Simply Wall St.

10 months ago

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Amicus Therapeutics Full Year 2023 Earnings: EPS Misses Expectations
FOLD

Simply Wall St.

10 months ago

Amicus Therapeutics Full Year 2023 Earnings: EPS Misses Expectations

Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
FOLD

GlobeNewswire

10 months ago

Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript
FOLD

Insider Monkey

10 months ago

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript

Amicus' (FOLD) Q4 Earnings Beat, Revenues Meet Estimates
FOLD

Zacks

10 months ago

Amicus' (FOLD) Q4 Earnings Beat, Revenues Meet Estimates

FOLD

Thomson Reuters StreetEvents

10 months ago

Q4 2023 Amicus Therapeutics Inc Earnings Call

Amicus Therapeutics (FOLD) Reports Q4 Loss, Lags Revenue Estimates
FOLD

Zacks

10 months ago

Amicus Therapeutics (FOLD) Reports Q4 Loss, Lags Revenue Estimates

FOLD

GuruFocus.com

10 months ago

Amicus Therapeutics Inc (FOLD) Reports 21% Revenue Growth in 2023, Eyes Non-GAAP Profitability ...

Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
FOLD

GlobeNewswire

10 months ago

Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates

Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024
FOLD

GlobeNewswire

10 months ago

Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024

Share on Social Networks: